TG Therapeutics, Inc.
TGTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001001316
In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in TG Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 183
- +8 vs. Q2 2022
- Shares held
- 100.2M
- −6.21M (−5.8%) vs. Q2 2022
- Total value
- $594.6M
- +$142.0M (+31.4%) vs. Q2 2022
- New holders
- 32
- 63 more added
- Sold out
- 24
- 56 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TGTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 431 | $6.10B |
| Q1 2026 | 365 | $3.50B |
| Q4 2025 | 352 | $3.07B |
| Q3 2025 | 354 | $3.58B |
| Q2 2025 | 356 | $3.65B |
| Q1 2025 | 376 | $3.90B |
| Q4 2024 | 331 | $2.92B |
| Q3 2024 | 308 | $2.38B |
| Q2 2024 | 259 | $1.66B |
| Q1 2024 | 241 | $1.38B |
| Q4 2023 | 236 | $1.55B |
| Q3 2023 | 236 | $756.4M |
| Q2 2023 | 244 | $2.19B |
| Q1 2023 | 214 | $1.43B |
| Q4 2022 | 198 | $1.11B |
| Q3 2022 | 183 | $594.6M |
| Q2 2022 | 175 | $452.6M |
| Q1 2022 | 181 | $960.0M |
| Q4 2021 | 194 | $1.90B |
| Q3 2021 | 223 | $3.21B |
| Q2 2021 | 237 | $3.73B |
| Q1 2021 | 240 | $4.77B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding TG Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| GoalVest Advisory LLC | 0 | $0 | 0.00% | −1,284−100.0% | Sold out |
| Trustcore Financial Services, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Johnson Financial Group, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| American Portfolios Advisors | 0 | $0 | 0.00% | −210−100.0% | Sold out |
| Institutional & Family Asset Management, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |